Chaofeng Ding

1.4k total citations
26 papers, 1.1k citations indexed

About

Chaofeng Ding is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Chaofeng Ding has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Chaofeng Ding's work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Chaofeng Ding is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Chaofeng Ding collaborates with scholars based in China and Madagascar. Chaofeng Ding's co-authors include Shusen Zheng, Jian Wu, Haiyang Xie, Zhen Lv, Chengli Du, Chuanhui Peng, Shaobing Cheng, Heng Xiao, Lin Zhou and Lin Zhou and has published in prestigious journals such as Hepatology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Chaofeng Ding

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chaofeng Ding China 18 833 645 143 116 73 26 1.1k
Peiguo Cao China 18 581 0.7× 496 0.8× 168 1.2× 130 1.1× 90 1.2× 58 878
Shengni Hua China 16 829 1.0× 587 0.9× 253 1.8× 122 1.1× 65 0.9× 22 1.1k
Wendi Hu China 14 835 1.0× 577 0.9× 141 1.0× 143 1.2× 66 0.9× 23 1.0k
Chuanhui Peng China 17 1.3k 1.5× 908 1.4× 166 1.2× 139 1.2× 77 1.1× 28 1.5k
Hongwei Li China 18 971 1.2× 888 1.4× 118 0.8× 57 0.5× 82 1.1× 50 1.2k
Runping Fang China 18 733 0.9× 403 0.6× 154 1.1× 70 0.6× 105 1.4× 26 943
Zhangqian Chen China 14 700 0.8× 421 0.7× 227 1.6× 115 1.0× 50 0.7× 19 961
Romain Riscal United States 9 492 0.6× 356 0.6× 192 1.3× 118 1.0× 95 1.3× 12 822
Hengyu Li China 14 623 0.7× 520 0.8× 145 1.0× 49 0.4× 57 0.8× 28 838

Countries citing papers authored by Chaofeng Ding

Since Specialization
Citations

This map shows the geographic impact of Chaofeng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaofeng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaofeng Ding more than expected).

Fields of papers citing papers by Chaofeng Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaofeng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaofeng Ding. The network helps show where Chaofeng Ding may publish in the future.

Co-authorship network of co-authors of Chaofeng Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Chaofeng Ding. A scholar is included among the top collaborators of Chaofeng Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaofeng Ding. Chaofeng Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ding, Bo, et al.. (2025). Advances in improving the efficacy of anti-PD-1/PD-L1 therapy in intrahepatic cholangiocarcinoma. Critical Reviews in Oncology/Hematology. 213. 104784–104784. 1 indexed citations
3.
4.
Chen, Junru, Chaofeng Ding, Yunhao Chen, et al.. (2020). ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway. Cancer Letters. 502. 154–165. 162 indexed citations
5.
Chen, Junru, Chaofeng Ding, Yunhao Chen, et al.. (2020). ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis. Oncogenesis. 9(4). 42–42. 71 indexed citations
6.
Weng, Xiaoyu, Jingbang Wu, Zhen Lv, et al.. (2019). Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5. EBioMedicine. 44. 225–236. 24 indexed citations
7.
Chen, Diyu, et al.. (2018). Cystic lymphangioma of pancreas. Medicine. 97(28). e11238–e11238. 2 indexed citations
8.
Peng, Chuanhui, Wendi Hu, Xiaoyu Weng, et al.. (2017). Over Expression of Long Non-Coding RNA PANDA Promotes Hepatocellular Carcinoma by Inhibiting Senescence Associated Inflammatory Factor IL8. Scientific Reports. 7(1). 4186–4186. 28 indexed citations
9.
Cheng, Shaobing, Chaofeng Ding, Chuanhui Peng, et al.. (2016). Downregulation of Peptidylprolyl isomerase A promotes cell death and enhances doxorubicin-induced apoptosis in hepatocellular carcinoma. Gene. 591(1). 236–244. 24 indexed citations
10.
Cheng, Shaobing, Xu Jiang, Chaofeng Ding, et al.. (2016). Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 17(8). 1373–1373. 28 indexed citations
11.
Du, Chengli, Xiaoyu Weng, Wendi Hu, et al.. (2015). Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 34(1). 67–67. 61 indexed citations
12.
Xu, Xiaofeng, Shaobing Cheng, Chaofeng Ding, et al.. (2014). Identification of bile biomarkers of biliary tract cancer through a liquid chromatography/mass spectrometry-based metabolomic method. Molecular Medicine Reports. 11(3). 2191–2198. 18 indexed citations
13.
Ding, Chaofeng, Zhe Yang, Zhen Lv, et al.. (2014). Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients. Oncology Letters. 9(2). 955–963. 110 indexed citations
14.
Xiao, Heng, Rongliang Tong, Shaobing Cheng, et al.. (2014). BAG3 and HIF-1αCoexpression Detected by Immunohistochemistry Correlated with Prognosis in Hepatocellular Carcinoma after Liver Transplantation. BioMed Research International. 2014. 1–9. 17 indexed citations
15.
Du, Chengli, Zhen Lv, Linping Cao, et al.. (2014). MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2. Journal of Translational Medicine. 12(1). 259–259. 100 indexed citations
16.
Xiao, Heng, Rongliang Tong, Chaofeng Ding, et al.. (2014). γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition. Oncotarget. 6(4). 2180–2192. 34 indexed citations
17.
Ding, Chaofeng, Shaobing Cheng, Zhe Yang, et al.. (2014). Long Non-Coding RNA HOTAIR Promotes Cell Migration and Invasion via Down-Regulation of RNA Binding Motif Protein 38 in Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences. 15(3). 4060–4076. 140 indexed citations
18.
Wu, Jian, Chengli Du, Zhen Lv, et al.. (2013). The Up-Regulation of Histone Deacetylase 8 Promotes Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 58(12). 3545–3553. 86 indexed citations
19.
Xiao, Heng, Shaobing Cheng, Rongliang Tong, et al.. (2013). BAG3 regulates epithelial–mesenchymal transition and angiogenesis in human hepatocellular carcinoma. Laboratory Investigation. 94(3). 252–261. 41 indexed citations
20.
Feng, Xiaoning, et al.. (2011). Technical aspects of biliary reconstruction in adult living donor liver transplantation. Hepatobiliary & pancreatic diseases international. 10(2). 136–142. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peiguo Cao Breakdown of academic impact, for papers by Shengni Hua Breakdown of academic impact, for papers by Wendi Hu Breakdown of academic impact, for papers by Chuanhui Peng Breakdown of academic impact, for papers by Hongwei Li Breakdown of academic impact, for papers by Runping Fang Breakdown of academic impact, for papers by Zhangqian Chen Breakdown of academic impact, for papers by Romain Riscal Breakdown of academic impact, for papers by Hengyu Li
Rankless by CCL
2026